Aggressive T-Cell Non-Hodgkin Lymphoma — Trials

Aggressive T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

289 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 62
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 21%
Top sponsor: City of Hope Medical Center
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01501136	Treatment of Natural Killer/T Cell Lymphoma-I/II(CTTNKTL-I/II)	unknown	Phase 4	200	Mingzhi ZhangOTHER	1	Jul 17, 2015	clinicaltrials
NCT01501149	Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ(CTTNKTL-Ⅲ/Ⅳ)	unknown	Phase 4	80	Mingzhi ZhangOTHER	1	Jul 17, 2015	clinicaltrials